Article · 2 Jun 2026
Conference abstract
Development of �second-generation� forms of FGF-1 for therapeutic application
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Fibroblast growth factor-1 (FGF-1) is a candidate growth factor for the treatment of chronic diabetic ulcers and other ischemic diseases. However, the relatively low thermal stability of FGF-1 makes it a poor candidate as a pharmaceutical compound. Formulation with soluble heparin substantially increases the thermo stability of FGF-1; however, while this approach to stabilizing FGF-1 improves the aggregation, storage and reconstitution properties it adds a number of undesirable cost and safety issues associated with heparin. Mutations that either stabilize FGF-1 or eliminate buried reactive thiols improve the in vitro functional half-life, protease resistance, and mitogenic activity in the absence of heparin. Pharmacokinetic (PK) studies of such mutants identify an additional undesirable consequence of heparin additive in the formulation; namely, it increases the endocrine-like properties of IV bolus FGF-1, and therefore also increases the probability of mitogenic activity at a distance from the site of delivery. Mutant FGF-1 with a diminished heparin binding site shows that heparan sulfate proteoglycan (HSPG) is the major effectors of the peripheral compartment in the pharmacokinetics of FGF-1; consequently, mutations that can enhance HSPG affinity can increase the mean residence time. Mutant FGF-1 proteins that do not require heparin in their formulation can therefore provide a number of important benefits for human therapeutic application.
Keywords
Subjects
Genetics & Molecular BiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Stem Cell Research & Therapy.
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Stem Cell Research & Therapy
- SubjectGenetics & Molecular Biology
- BylineArticles whose byline prints “Michael Blaber”
